JC
BMY icon

Jacobs & Co’s Bristol-Myers Squibb BMY Stock Holding History

Jacobs & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Hold
3,580
– – 0.02% 132
2026
Q1 		$217K Buy
+3,580
New +$209K 0.02% 121
2025
Q2 		– Sell
-4,205
Closed -$256K – 126
2025
Q1 		$256K Hold
4,205
– – 0.03% 111
2024
Q4 		$237K Sell
4,205
-264
-6% -$14.8K 0.02% 118
2024
Q3 		$231K Sell
4,469
-22,820
-84% -$1.07M 0.02% 123
2024
Q2 		$1.13M Sell
27,289
-101,039
-79% -$4.52M 0.12% 89
2024
Q1 		$6.96M Buy
128,328
+1,014
+0.8% +$51.7K 0.74% 57
2023
Q4 		$6.53M Buy
127,314
+907
+0.7% +$47.6K 0.74% 57
2023
Q3 		$7.34M Buy
126,407
+278
+0.2% +$17K 0.91% 49
2023
Q2 		$8.06M Buy
126,129
+555
+0.4% +$37.2K 0.96% 48
2023
Q1 		$8.7M Buy
125,574
+2,641
+2% +$186K 1.07% 42
2022
Q4 		$8.85M Sell
122,933
-875
-0.7% -$66K 1.15% 37
2022
Q3 		$8.8M Sell
123,808
-384
-0.3% -$27.9K 1.27% 32
2022
Q2 		$9.56M Sell
124,192
-11,167
-8% -$850K 1.28% 34
2022
Q1 		$9.88M Sell
135,359
-762
-0.6% -$51.2K 1.09% 43
2021
Q4 		$8.49M Buy
136,121
+12,301
+10% +$722K 0.88% 52
2021
Q3 		$7.33M Buy
123,820
+11,935
+11% +$786K 0.84% 55
2021
Q2 		$7.48M Buy
111,885
+44
+0% +$2.87K 0.86% 50
2021
Q1 		$7.06M Buy
111,841
+3,271
+3% +$204K 0.86% 51
2020
Q4 		$6.73M Buy
108,570
+5,005
+5% +$308K 0.87% 49
2020
Q3 		$6.24M Buy
103,565
+9,139
+10% +$550K 0.91% 48
2020
Q2 		$5.55M Buy
94,426
+7,921
+9% +$474K 0.9% 42
2020
Q1 		$4.82M Sell
86,505
-7,162
-8% -$438K 0.93% 40
2019
Q4 		$6.01M Buy
93,667
+25,637
+38% +$1.47M 0.91% 46
2019
Q3 		$3.45M Buy
68,030
+2,382
+4% +$112K 0.56% 66
2019
Q2 		$2.98M Buy
65,648
+886
+1% +$41.3K 0.48% 71
2019
Q1 		$3.09M Buy
64,762
+1,255
+2% +$62.5K 0.53% 68
2018
Q4 		$3.3M Sell
63,507
-4,068
-6% -$219K 0.65% 58
2018
Q3 		$4.2M Sell
67,575
-149
-0.2% -$8.84K 0.71% 56
2018
Q2 		$3.75M Sell
67,724
-1,393
-2% -$75.2K 0.68% 57
2018
Q1 		$4.37M Buy
69,117
+380
+0.6% +$24.4K 0.81% 49
2017
Q4 		$4.17M Buy
68,737
+961
+1% +$60.1K 0.75% 55
2017
Q3 		$4.32M Buy
67,776
+3,676
+6% +$215K 0.81% 55
2017
Q2 		$3.57M Buy
64,100
+4,305
+7% +$234K 0.7% 61
2017
Q1 		$3.25M Buy
59,795
+5,523
+10% +$303K 0.67% 64
2016
Q4 		$3.17M Buy
54,272
+6,134
+13% +$335K 0.69% 59
2016
Q3 		$2.6M Buy
48,138
+24,754
+106% +$1.59M 0.58% 68
2016
Q2 		$1.72M Sell
23,384
-39
-0.2% -$2.76K 0.4% 77
2016
Q1 		$1.5M Buy
23,423
+845
+4% +$53.3K 0.36% 81
2015
Q4 		$1.43M Buy
22,578
+210
+0.9% +$13.9K 0.37% 79
2015
Q3 		$1.32M Hold
22,368
– – 0.35% 83
2015
Q2 		$1.49M Sell
22,368
-400
-2% -$26.4K 0.37% 80
2015
Q1 		$1.47M Sell
22,768
-200
-0.9% -$12.5K 0.37% 81
2014
Q4 		$1.35M Buy
22,968
+2,360
+11% +$133K 0.36% 82
2014
Q3 		$1.05M Buy
20,608
+5,356
+35% +$268K 0.3% 86
2014
Q2 		$740K Buy
15,252
+2,430
+19% +$120K 0.21% 94
2014
Q1 		$666K Hold
12,822
– – 0.21% 95
2013
Q4 		$681K Hold
12,822
– – 0.22% 95
2013
Q3 		$593K Sell
12,822
-1,750
-12% -$76.8K 0.21% 92
2013
Q2 		$651K Buy
+14,572
New +$633K 0.24% 90

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Jacobs & Co's BMY Position: Q2 2026 in Review

Jacobs & Co held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,580 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #132.

Jacobs & Co first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $9.88M in Q1 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Jacobs & Co held 3,580 shares of Bristol-Myers Squibb worth $206K as of Q2 2026.
  • Jacobs & Co left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Jacobs & Co's portfolio in Q2 2026, its #132 holding.
  • Jacobs & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
  • Jacobs & Co's Bristol-Myers Squibb position peaked at $9.88M in Q1 2022.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.